Journal of Cataract & Refractive Surgery
Volume 32, Issue 8 , Pages 1292-1295, August 2006

Laser in situ keratomileusis in patients with autoimmune diseases

  • Ronald J. Smith, MD, MPH
    • ,
  • Robert K. Maloney, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Robert K. Maloney, MD, Maloney Vision Institute, 10921 Wilshire Boulevard, Suite 900, Los Angeles, California 90024, USA.

From the Maloney Vision Institute, Los Angeles, California, USA

Accepted 4 February 2006.

Purpose

To evaluate the safety of laser in situ keratomileusis (LASIK) in patients with autoimmune diseases.

Setting

Private clinical practice.

Methods

In this retrospective case series, the records of patients who had LASIK at the Maloney Vision Institute between June 1, 1998, and October 1, 2004, were reviewed for a history of autoimmune disease including systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, scleroderma, inflammatory bowel disease, Graves' disease, Reiter's syndrome, and Hashimoto's disease. The records were reviewed for corneal and scleral complications of autoimmune disease after LASIK.

Results

Forty-nine eyes of 26 patients with inactive or stable autoimmune disease were identified. No eye developed corneal thinning, melting, persistent epithelial defect, persistent keratitis, scleral thinning, scleritis, or scleromalacia.

Conclusion

Laser in situ keratomileusis may be a reasonable option in patients with well-controlled or inactive autoimmune disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented in part at the ASCRS Symposium on Cataract, IOL and Refractive, San Diego, California, USA, May 2004.Neither author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(06)00552-9

doi:10.1016/j.jcrs.2006.02.059

Journal of Cataract & Refractive Surgery
Volume 32, Issue 8 , Pages 1292-1295, August 2006

Article Tools